EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

MOLECULAR STUDIES OF EXTENDED SPECTRUM BETA-LACTAMASE-PRODUCING BACTERIA ISOLATED FROM CLINICAL SAMPLES IN IMO STATE, SOUTH EASTERN NIGERIA.

Chinyere N. Ohalete* and Ifeanyi O. C. Obiajuru

ABSTRACT

Background: Antibiotic – resistant bacterial infections constitute a major health challenge in Nigeria. Many hospitals that encounter these infections lack facilities to detect beta lactamase producing bacteria in circulation. Lack of facilities for ESβL detection leads to incorrect identification of antibiotic resistance which may lead to inappropriate antibiotic prescription. This in turn may lead bacteria to produce new antibiotic - resistant genes by selective pressure. The objective of this study was to determine the existence of extended spectrum beta lactamase producing bacteria (ESβL) in clinical samples and carry out molecular studies on them to determine their nature. Methods: A total of 602 multi antibiotic resistant (MAR) gram negative bacterial isolates comprising, 294 Escherichia coli, 186 Klebsiella species and 122 Pseudomonas aeruginosa were collected from 3 tertiary health institutions in Imo State and examined for beta lactamase production. Antimicrobial resistance profile was determined by the Kirby-Bauer technique. Phenotypic expression of β-lactamase production was performed by the double disk diffusion method. Molecular studies were carried out on ESβL-producing strains of the bacterial isolates. Genomic DNA extraction was carried out by alkaline lysis method and hybridization effected with primers of the three β-lactamases genes, TEM, SHV and CTX-M. The isolated DNA and plasmids were analysed by agarose gel electrophoresis. Plasmid curing was effected with acridine-orange. Gel electrophoretic plasmid profiling was carried out using Thermo-Scientific extraction kit as described by the manufacturers. Polymerase chain reaction (PCR) amplification of extended spectrum beta lactamase gene was carried out using primers for SHV, TEM and CTX-M genes. Bacterial genomic DNA was used as substrate with specific primers for PCR reactions. The PCR amplicon size was calculated by comparison to molecular weight size marker. Results: The results showed that 391 (64. 9%) out of 602 multi antibiotic resistant bacterial isolates comprising of 67.6% Escherichia coli, 64.7% Klebsiella species and 57.7% Pseudomonas aeruginosa were positive for extended spectrum beta lactamase (ESβL) production. Thus the prevalence of (ESβL) bacteria in clinical bacterial isolates was highest (67.6%) amongst E. coli followed by Klebsiella species (64.7%) and P. aeruginosa (57.7%). Gel electrophoresis of the amplified (PCR) genomic products showed that 36.7% were positive for TEM, 66.7% for SHV, and 23.3% for CTX-M genes. Phenotypic screening of isolates for extended spectrum beta-lactamase production before curing showed high resistance to the β-lactam antimicrobials and the β-lactamases inhibitors of amoxicillin/clavulanic acid combination. However, analysis of post curing showed a great reduction in rates of ESβL positive isolates examined. E. coli 4(40%), P. aeruginosa 4(40%) and Klebsiella species 3 (30%) were found to habour ESβL genes as against, E. coli 8(80%), Klebsiella species 6 (60%) and P. aeruginosa 9(90%) before curing. Conclusion: Beta – lactamase – producing bacterial infections are common in Imo State, South eastern Nigeria. They are responsible for 64. 9% of multi antibiotic resistant bacterial infections encountered in hospitals in Imo State. The most common genes associated with ESβL production in Imo State are SHV, TEM and CTX – M.

Keywords: Escherichia coli, Pseudomonas aeruginosa.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2024 issue has been successfully launched on NOVEMBER 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along witcertificate to promote resear activity of scholar.

Best Article of current issue :

Dr. Kartik Neog
Download Article : Click here